| Pharmaceutical active ingredients: |
| Ethinyl EstradiolNorethindrone |
| Available forms, composition and doses of Norcept-E: |
| Tablets; Oral-21; Ethinyl Estradiol 0.035 mg; Norethindrone 1 mgTablets; Oral-28; Ethinyl Estradiol 0.035 mg; Norethindrone 1 mg |
| Norcept-E medical category: |
| Human:Oral contraceptives |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| G03AA05 - Norethisterone and estrogenG03AB04 - Norethisterone and estrogenG03CA01 - Ethinylestradiol |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Ortho McNeil PharmaceuticalsGynoPharma |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Norcainum | Benzocaine | Unidentified Pharmaceutical Company |
| Norcalcin | Calcitonin | Biomedica-Chemica |
| Norcalciphos | Calcium Borogluconate; Dextrose; Magnesium Borogluconate; Phosphorus | Pfizer; Norden Laboratories |
| Norcephin | Ceftriaxone Sodium | Alkem Laboratories; Cris Pharma House |
| Norcept | Ethinyl Estradiol; Norethindrone | Unidentified Pharmaceutical Company |
| Norcet | Acetaminophen; Hydrocodone Bitartrate | Abana; King Pharmaceuticals |
| Norcholesterol Iode, I-131 | 6-Iodomethylnorcholesterol, I-131 | CIS Bio International |
| Norcholine | Deanol | Unidentified Pharmaceutical Company |
| Norciden | Danazol | Kendrick Laboratorios |
| Norcin | Norfloxacin | Siam Medicare; Utopian, Thailand |